These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 37422473)

  • 21. UBE2S mediates tumor progression via SOX6/β-Catenin signaling in endometrial cancer.
    Lin M; Lei T; Zheng J; Chen S; Du L; Xie H
    Int J Biochem Cell Biol; 2019 Apr; 109():17-22. PubMed ID: 30690078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ROC1 promotes the malignant progression of bladder cancer by regulating p-IκBα/NF-κB signaling.
    Wu Q; Zhou X; Li P; Ding M; You S; Xu Z; Ye J; Chen X; Tan M; Wang J; Wang W; Qiu J
    J Exp Clin Cancer Res; 2021 May; 40(1):158. PubMed ID: 33962660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficient APC/C substrate degradation in cells undergoing mitotic exit depends on K11 ubiquitin linkages.
    Min M; Mevissen TE; De Luca M; Komander D; Lindon C
    Mol Biol Cell; 2015 Dec; 26(24):4325-32. PubMed ID: 26446837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ubiquitination-Related Molecular Subtypes and a Novel Prognostic Index for Bladder Cancer Patients.
    Cai H; Chen H; Huang Q; Zhu JM; Ke ZB; Lin YZ; Zheng QS; Wei Y; Xu N; Xue XY
    Pathol Oncol Res; 2021; 27():1609941. PubMed ID: 34776794
    [No Abstract]   [Full Text] [Related]  

  • 25. Ube2v1-mediated ubiquitination and degradation of Sirt1 promotes metastasis of colorectal cancer by epigenetically suppressing autophagy.
    Shen T; Cai LD; Liu YH; Li S; Gan WJ; Li XM; Wang JR; Guo PD; Zhou Q; Lu XX; Sun LN; Li JM
    J Hematol Oncol; 2018 Jul; 11(1):95. PubMed ID: 30016968
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HSF1 facilitates the multistep process of lymphatic metastasis in bladder cancer via a novel PRMT5-WDR5-dependent transcriptional program.
    Huang M; Dong W; Xie R; Wu J; Su Q; Li W; Yao K; Chen Y; Zhou Q; Zhang Q; Li W; Cheng L; Peng S; Chen S; Huang J; Chen X; Lin T
    Cancer Commun (Lond); 2022 May; 42(5):447-470. PubMed ID: 35434944
    [TBL] [Abstract][Full Text] [Related]  

  • 27. UBE2S associated with OSCC proliferation by promotion of P21 degradation via the ubiquitin-proteasome system.
    Yoshimura S; Kasamatsu A; Nakashima D; Iyoda M; Kasama H; Saito T; Takahara T; Endo-Sakamoto Y; Shiiba M; Tanzawa H; Uzawa K
    Biochem Biophys Res Commun; 2017 Apr; 485(4):820-825. PubMed ID: 28257844
    [TBL] [Abstract][Full Text] [Related]  

  • 28. UBE2S promotes glycolysis in hepatocellular carcinoma by enhancing E3 enzyme-independent polyubiquitination of VHL.
    Zhang R; Li C; Zhang S; Kong L; Liu Z; Guo Y; Sun Y; Zhang C; Yong Y; Lv J; Lu M; Liu M; Wu D; Zhang T; Yang H; Wei D; Chen Z; Bian H
    Clin Mol Hepatol; 2024 Jun; ():. PubMed ID: 38915206
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exosomal long noncoding RNA LNMAT2 promotes lymphatic metastasis in bladder cancer.
    Chen C; Luo Y; He W; Zhao Y; Kong Y; Liu H; Zhong G; Li Y; Li J; Huang J; Chen R; Lin T
    J Clin Invest; 2020 Jan; 130(1):404-421. PubMed ID: 31593555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RNF8- and Ube2S-Dependent Ubiquitin Lysine 11-Linkage Modification in Response to DNA Damage.
    Paul A; Wang B
    Mol Cell; 2017 May; 66(4):458-472.e5. PubMed ID: 28525740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. UBE2S promotes the proliferation and survival of human lung adenocarcinoma cells.
    Liu Z; Xu L
    BMB Rep; 2018 Dec; 51(12):642-647. PubMed ID: 30545437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Knockout of UBE2S inhibits the proliferation of gastric cancer cells and induces apoptosis by FAS-mediated death receptor pathway.
    Zhao R; Yu Z; Mao X; Zheng Y; Wang Y; Zhou Y
    Exp Cell Res; 2022 Oct; 419(1):113293. PubMed ID: 35863455
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Importin-11 overexpression promotes the migration, invasion, and progression of bladder cancer associated with the deregulation of CDKN1A and THBS1.
    Zhao J; Shi L; Zeng S; Ma C; Xu W; Zhang Z; Liu Q; Zhang P; Sun Y; Xu C
    Urol Oncol; 2018 Jun; 36(6):311.e1-311.e13. PubMed ID: 29602637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contributions of UBE2C and UBE2S to meiotic progression of porcine oocytes.
    Fujioka YA; Onuma A; Fujii W; Sugiura K; Naito K
    J Reprod Dev; 2018 Jun; 64(3):253-259. PubMed ID: 29576589
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic value of ubiquitin-conjugating enzyme E2 S overexpression in hepatocellular carcinoma.
    Ma Y; Li K; Li S; Liang B; Liu Q; Mo Z
    Int J Biol Macromol; 2018 Nov; 119():225-231. PubMed ID: 30041036
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of a physiological E2 module for the human anaphase-promoting complex.
    Williamson A; Wickliffe KE; Mellone BG; Song L; Karpen GH; Rape M
    Proc Natl Acad Sci U S A; 2009 Oct; 106(43):18213-8. PubMed ID: 19822757
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TRIM21 is a druggable target for the treatment of metastatic colorectal cancer through ubiquitination and activation of MST2.
    Liu YX; Wan S; Yang XQ; Wang Y; Gan WJ; Ye WL; He XS; Chen JJ; Yang Y; Yang XM; Guo X; Gao XJ; Lu YT; Deng ZY; Hu G; Wu H
    Cell Chem Biol; 2023 Jul; 30(7):709-725.e6. PubMed ID: 37354905
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ubiquitin-conjugating enzyme Ubc13 controls breast cancer metastasis through a TAK1-p38 MAP kinase cascade.
    Wu X; Zhang W; Font-Burgada J; Palmer T; Hamil AS; Biswas SK; Poidinger M; Borcherding N; Xie Q; Ellies LG; Lytle NK; Wu LW; Fox RG; Yang J; Dowdy SF; Reya T; Karin M
    Proc Natl Acad Sci U S A; 2014 Sep; 111(38):13870-5. PubMed ID: 25189770
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sequential ubiquitination and deubiquitination enzymes synchronize the dual sensor and effector functions of TRIM21.
    Fletcher AJ; Mallery DL; Watkinson RE; Dickson CF; James LC
    Proc Natl Acad Sci U S A; 2015 Aug; 112(32):10014-9. PubMed ID: 26150489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The roles and mechanism of IFIT5 in bladder cancer epithelial-mesenchymal transition and progression.
    Huang J; Lo UG; Wu S; Wang B; Pong RC; Lai CH; Lin H; He D; Hsieh JT; Wu K
    Cell Death Dis; 2019 Jun; 10(6):437. PubMed ID: 31164632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.